NCT01522794View on ClinicalTrials.gov

Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions
Anemia of Chronic Disease
Interventions
DRUG

NOX-H94

single i.v. infusion

DRUG

Placebo solution

single i.v. infusion

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

TME Pharma AG

INDUSTRY

NCT01522794 - Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model | Biotech Hunter | Biotech Hunter